atrasentan has been researched along with nitroglycerin in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (nitroglycerin) | Trials (nitroglycerin) | Recent Studies (post-2010) (nitroglycerin) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 12,659 | 2,240 | 1,398 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abassi, Z; Bishara, B; Hoffman, A; Karram, T; Khatib, S; Winaver, J | 1 |
1 other study(ies) available for atrasentan and nitroglycerin
| Article | Year |
|---|---|
Adverse effects of pneumoperitoneum on renal function: involvement of the endothelin and nitric oxide systems.
Topics: Animals; Atrasentan; Blood Pressure; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Nitroglycerin; Pneumoperitoneum, Artificial; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Circulation; Renal Plasma Flow; Vasodilator Agents | 2008 |